Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy
Public ClinicalTrials.gov record NCT03515356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy: A Pilot RCT
Study identification
- NCT ID
- NCT03515356
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Other
- Enrollment
- 54 participants
Conditions and interventions
Conditions
Interventions
- MI-Walk Intervention Behavioral
- Physical Activity Education Pamphlet Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 12, 2018
- Primary completion
- Jun 23, 2019
- Completion
- Jun 23, 2019
- Last update posted
- Mar 8, 2020
2018 – 2019
United States locations
- U.S. sites
- 7
- U.S. states
- 1
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The University of Michigan Comprehensive Cancer Center | Ann Arbor | Michigan | 48109 | — |
| St. Joseph Mercy Hospital | Ann Arbor | Michigan | 48197 | — |
| St. Joseph Mercy Brighton Health Center | Brighton | Michigan | 48114 | — |
| Brighton Center for Specialty Care | Brighton | Michigan | 48116 | — |
| St. Joseph Mercy Health System | Canton | Michigan | 48188 | — |
| St. Joseph Mercy Chelsea Cancer Center | Chelsea | Michigan | 48118 | — |
| The University of Michigan Northville Health Center | Northville | Michigan | 48168 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03515356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 8, 2020 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03515356 live on ClinicalTrials.gov.